Nausea: a review of pathophysiology and therapeutics

The sensation of nausea is a common occurrence with diverse causes and a significant disease burden. Nausea is considered to function as a protective mechanism, warning the organism to avoid potential toxic ingestion. Less adaptive circumstances are also associated with nausea, including post-operative nausea, chemotherapy-induced nausea, and motion sickness. A common definition of nausea identifies the symptom as a precursor to the act of vomiting. The interaction, though present, does not appear to be a simple relationship. Nausea is unfortunately the ‘neglected symptom’, with current accepted therapy generally directed at improving gastrointestinal motility or acting to relieve emesis. Improved understanding of the pathophysiological basis of nausea has important implications for exploiting novel mechanisms or developing novel therapies for nausea relief.

[1]  P. Moayyedi,et al.  Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. , 2015, Gastroenterology.

[2]  L. Doan,et al.  Neuroplasticity Underlying the Comorbidity of Pain and Depression , 2015, Neural plasticity.

[3]  Sergio Cerutti,et al.  Brain Circuitry Supporting Multi-Organ Autonomic Outflow in Response to Nausea. , 2014, Cerebral cortex.

[4]  K. Koch Gastric dysrhythmias: a potential objective measure of nausea , 2014, Experimental Brain Research.

[5]  C. C. Horn The medical implications of gastrointestinal vagal afferent pathways in nausea and vomiting. , 2014, Current pharmaceutical design.

[6]  T. Guttuso Gabapentin’s anti-nausea and anti-emetic effects: a review , 2014, Experimental Brain Research.

[7]  T. Schnitzer,et al.  Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. , 2013, Brain : a journal of neurology.

[8]  H. Mousa,et al.  Improvement of quality of life and symptoms after gastric electrical stimulation in children with functional dyspepsia , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[9]  Kyungmo Park,et al.  The brain circuitry underlying the temporal evolution of nausea in humans. , 2013, Cerebral cortex.

[10]  R. Navari Management of Chemotherapy-Induced Nausea and Vomiting , 2013, Drugs.

[11]  J. Gaughan,et al.  Surgical Outcomes After Gastric Electric Stimulator Placement for Refractory Gastroparesis , 2013, Journal of Gastrointestinal Surgery.

[12]  Q. Aziz,et al.  Anti-emetic and emetic effects of erythromycin in Suncus murinus: role of vagal nerve activation, gastric motility stimulation and motilin receptors. , 2013, European journal of pharmacology.

[13]  G. Wall,et al.  Gastroparesis-Associated Refractory Nausea Treated with Aprepitant , 2012, The Annals of pharmacotherapy.

[14]  Z. Amiri,et al.  Effects of gabapentin on postoperative pain, nausea and vomiting after abdominal hysterectomy: a double blind randomized clinical trial , 2012, Archives of Gynecology and Obstetrics.

[15]  M. Rahmadi,et al.  Usefulness of Olanzapine as an Adjunct to Opioid Treatment and for the Treatment of Neuropathic Pain , 2012, Anesthesiology.

[16]  Riccardo Barbieri,et al.  A combined HRV-fMRI approach to assess cortical control of cardiovagal modulation by motion sickness , 2011, 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[17]  Gianrico Farrugia,et al.  Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[18]  E. Brown,et al.  Static and dynamic autonomic response with increasing nausea perception. , 2011, Aviation, space, and environmental medicine.

[19]  C. Slovis,et al.  A randomized, placebo-controlled trial of ondansetron, metoclopramide, and promethazine in adults. , 2011, The American journal of emergency medicine.

[20]  Meng‐chao Wu,et al.  Acupuncture versus metoclopramide in treatment of postoperative gastroparesis syndrome in abdominal surgical patients: a randomized controlled trial. , 2010, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[21]  E. Muth,et al.  Acute tryptophan depletion increases experimental nausea but also induces hunger in healthy female subjects , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[22]  M. Kris,et al.  Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  L. Becerra,et al.  The Pain Imaging Revolution: Advancing Pain Into the 21st Century , 2010, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[24]  Z. Lin,et al.  Mechanisms of symptomatic improvement after gastric electrical stimulation in gastroparetic patients , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[25]  W. Hasler,et al.  Coupling and propagation of normal and dysrhythmic gastric slow waves during acute hyperglycaemia in healthy humans , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[26]  K. Dhatariya,et al.  A case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant , 2009, Nature Reviews Endocrinology.

[27]  J. Chen,et al.  Effects of dual pulse gastric electrical stimulation on gastric tone and compliance in dogs. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[28]  J. Madsen,et al.  A randomized, placebo‐controlled, crossover, double‐blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humans , 2008, Alimentary pharmacology & therapeutics.

[29]  K. Olden,et al.  Nausea and vomiting , 2008, Current treatment options in gastroenterology.

[30]  Charles C. Horn,et al.  Why is the neurobiology of nausea and vomiting so important? , 2008, Appetite.

[31]  Z. Lin,et al.  Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy 1 , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[32]  R. Clouse,et al.  Tricyclic Antidepressants for Chronic Vomiting in Diabetic Patients , 2007, Digestive Diseases and Sciences.

[33]  D. Chialvo,et al.  Chronic Pain and the Emotional Brain: Specific Brain Activity Associated with Spontaneous Fluctuations of Intensity of Chronic Back Pain , 2006, The Journal of Neuroscience.

[34]  G. Sanger,et al.  Treatment of nausea and vomiting: Gaps in our knowledge , 2006, Autonomic Neuroscience.

[35]  P. Enck,et al.  Functional cortical imaging of nausea and vomiting: A possible approach , 2006, Autonomic Neuroscience.

[36]  E. Muth Motion and space sickness: Intestinal and autonomic correlates , 2006, Autonomic Neuroscience.

[37]  F. Rodolá Midazolam as an anti-emetic. , 2006, European review for medical and pharmacological sciences.

[38]  G. Sanger,et al.  Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin , 2006, Neuroscience Letters.

[39]  M. Kamm,et al.  Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study , 2005, Gut.

[40]  R. Holloway,et al.  Responsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report. , 2005, Journal of neurosurgery.

[41]  L. Einhorn,et al.  A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group study , 2005, Supportive Care in Cancer.

[42]  Stuart J Pocock,et al.  Soya food intake and risk of endometrial cancer among Chinese women in Shanghai: population based case-control study , 2004, BMJ : British Medical Journal.

[43]  W. Riedel,et al.  Acute tryptophan depletion slows gastric emptying in females , 2004, British Journal of Nutrition.

[44]  R. Scalley,et al.  Practical selection of antiemetics. , 2004, American family physician.

[45]  Sin-Ho Jung,et al.  A Phase I Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients: A Hoosier Oncology Group Study , 2004, Cancer investigation.

[46]  J. Griggs,et al.  Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer , 2003, The Lancet.

[47]  H. Parkman,et al.  Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force , 2003, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[48]  R. Stern The Psychophysiology of Nausea , 2002, Acta biologica Hungarica.

[49]  R. Chez,et al.  Ginger syrup as an antiemetic in early pregnancy. , 2002, Alternative therapies in health and medicine.

[50]  P. Gent,et al.  An overview of chemotherapy-induced emesis highlighting the role of lorazepam as adjuvant therapy. , 2002, International journal of palliative nursing.

[51]  A. Mykletun,et al.  The prevalence of nausea in the community: psychological, social and somatic factors. , 2002, General hospital psychiatry.

[52]  R. H. Rosen Management of Chemotherapy-Induced Nausea and Vomiting , 2002 .

[53]  P J Hornby,et al.  Central neurocircuitry associated with emesis. , 2001, The American journal of medicine.

[54]  G. Azzarello,et al.  Hypnosis in the Treatment of Anticipatory Nausea and Vomiting in Patients Receiving Cancer Chemotherapy , 2000, Oncology.

[55]  R. Stern,et al.  Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. , 2000, Journal of pain and symptom management.

[56]  J. Huizinga,et al.  Assessment of gastric emptying using a low fat meal: establishment of international control values , 2000, American Journal of Gastroenterology.

[57]  G. Morrow,et al.  Patient expectations as predictor of chemotherapy-induced nausea , 2000, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[58]  E. Ernst,et al.  Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. , 2000, British journal of anaesthesia.

[59]  R. Clouse,et al.  Cyclic vomiting syndrome in adults: clinical features and response to tricyclic antidepressants , 1999, American Journal of Gastroenterology.

[60]  Y. Taché Cyclic vomiting syndrome: the corticotropin-releasing-factor hypothesis. , 1999, Digestive diseases and sciences.

[61]  Miller Ad Central mechanisms of vomiting. , 1999 .

[62]  K. Freedland,et al.  Tricyclic Antidepressants for Functional Nausea and Vomiting (Clinical Outcome in 37 Patients) , 1998, Digestive Diseases and Sciences.

[63]  J. Tack,et al.  Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans , 1998, Gut.

[64]  K. Koch A noxious trio: nausea, gastric dysrhythmias and vasopressin , 1997, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[65]  S. Caras,et al.  The effect of intravenous vasopressin on gastric myoelectrical activity in human subjects , 1997, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[66]  M. Camilleri,et al.  Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. , 1997, The American journal of gastroenterology.

[67]  J F Golding,et al.  Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate. , 1997, British journal of clinical pharmacology.

[68]  W. Chey,et al.  Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness. , 1997, The American journal of physiology.

[69]  D. Porteous,et al.  Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice. , 1997, The American journal of physiology.

[70]  R. McCallum,et al.  Abnormal gastric myoelectrical activity and delayed gastric emptying in patients with symptoms suggestive of gastroparesis , 1996, Digestive Diseases and Sciences.

[71]  J. Galmiche,et al.  Erythromycin enhances fasting and postprandial proximal gastric tone in humans. , 1995, Gastroenterology.

[72]  W. Hasler,et al.  Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. , 1995, Gastroenterology.

[73]  H. Kooy,et al.  The prevention of radiosurgery-induced nausea and vomiting by ondansetron: evidence of a direct effect on the central nervous system chemoreceptor trigger zone. , 1994, Surgical neurology.

[74]  R. Stern,et al.  Hypothalamic and gastric myoelectrical responses during vection-induced nausea in healthy Chinese subjects. , 1993, The American journal of physiology.

[75]  R. Stern,et al.  Chinese hyper-susceptibility to vection-induced motion sickness. , 1993, Aviation, space, and environmental medicine.

[76]  R. Goucke,et al.  Reduction of dopamine release and postoperative emesis by benzodiazepines. , 1993, British journal of anaesthesia.

[77]  N. Koshikawa,et al.  Effects of midazolam and flunitrazepam on the release of dopamine from rat striatum measured by in vivo microdialysis. , 1993, British journal of anaesthesia.

[78]  Inge,et al.  Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. , 1992, Gastroenterology.

[79]  W. Katon,et al.  Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study. , 1992, The American journal of medicine.

[80]  A. White,et al.  The Responses Of Arginine Vasopressin And Adrenocorticotrophin To Nausea Induced By Ipecacuanha , 1990, Clinical endocrinology.

[81]  R. Stern,et al.  Vasopressin and oxytocin responses to illusory self-motion and nausea in man. , 1990, The Journal of clinical endocrinology and metabolism.

[82]  P. Kerlin,et al.  Postprandial antral hypomotility in patients with idiopathic nausea and vomiting. , 1989, Gut.

[83]  W. Samson,et al.  Apomorphine-induced nausea in humans: release of vasopressin and pancreatic polypeptide. , 1988, Gastroenterology.

[84]  J. Malagelada,et al.  Vomiting and the small intestine , 1982, Digestive Diseases and Sciences.

[85]  J. Dean,et al.  Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. , 1979, The New England journal of medicine.

[86]  M. Camilleri,et al.  Clinical Guideline: Management of Gastroparesis , 2013, The American Journal of Gastroenterology.

[87]  Anna Lee,et al.  Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. , 2009, The Cochrane database of systematic reviews.

[88]  D. M. Robinson,et al.  Aprepitant , 2012, Drugs.

[89]  N. Hanamura,et al.  Effect of Pancreatic Juice Reflux into Biliary Tract on N-Nitrosobis(2-oxopropyl)amine (BOP)-Induced Biliary Carcinogenesis in Syrian Hamsters , 2004, Digestive Diseases and Sciences.

[90]  H. Parkman,et al.  AGA technical review on nausea and vomiting. , 2001, Gastroenterology.

[91]  A. D. Miller Central mechanisms of vomiting. , 1999, Digestive diseases and sciences.

[92]  S H Uijtdehaage,et al.  Asian hypersusceptibility to motion sickness. , 1996, Human heredity.

[93]  R. D. Fisher,et al.  Elevation of plasma antidiuretic hormones (ADH) associated with chemotherapy-induced emesis in man. , 1982, Cancer treatment reports.